Managing Chemotherapy-Induced Nausea and Vomiting (CINV)

Modern antiemetic strategies and supportive measures that dramatically reduce treatment-related nausea

Key Points

• CINV is highly preventable with modern antiemetics — most patients on optimal regimens experience minimal nausea.
• Three distinct patterns exist: acute (0–24h), delayed (24h–5 days), and anticipatory (before treatment) CINV.
• Emetic risk of the chemotherapy regimen determines the antiemetic protocol — high-risk regimens require triple or quadruple therapy.
• Olanzapine 10mg nightly is now part of the standard four-drug regimen for highly emetogenic chemotherapy (HEC).
• Anticipatory CINV is best prevented by achieving excellent control from cycle 1; lorazepam the evening before can help.
• Contact your care team if you cannot keep fluids down for more than 24 hours or show signs of dehydration.

Understanding CINV

Chemotherapy-induced nausea and vomiting (CINV) was once considered an inevitable side effect of cancer treatment, but advances in antiemetic therapy over the past two decades have made it largely preventable. Understanding the distinct patterns of CINV is essential for effective prevention. Acute CINV occurs within the first 24 hours after chemotherapy administration, peaking at 5–6 hours. It is primarily mediated by serotonin (5-HT3) release from enterochromaffin cells in the gut, which stimulates the vagus nerve and the chemoreceptor trigger zone (CTZ) in the brainstem area postrema.…

Emetogenic Risk Classification

Not all chemotherapy agents carry the same emetic potential. The emetogenic risk classification guides antiemetic selection: High emetogenic chemotherapy (HEC, >90% without prophylaxis): cisplatin, cyclophosphamide ≥1500 mg/m², the AC combination (doxorubicin or epirubicin + cyclophosphamide, used in breast cancer), carmustine, dacarbazine, and streptozocin. These regimens require the most aggressive antiemetic prophylaxis. Moderate emetogenic chemotherapy (MEC, 30–90%): carboplatin, cyclophosphamide <1500 mg/m², doxorubicin (non-AC), epirubicin, ifosfamide, irinotecan, oxaliplatin, and…

Standard Antiemetic Regimens

Current MASCC, ASCO, and NCCN guidelines provide clear antiemetic prescribing frameworks based on emetic risk: For HEC (including AC combinations): Four-drug prophylaxis is now standard. The regimen includes an NK1 receptor antagonist (aprepitant 125mg PO day 1, then 80mg days 2–3; OR fosaprepitant 150mg IV day 1; OR netupitant/palonosetron [NEPA] capsule day 1; OR rolapitant), PLUS a 5-HT3 antagonist (palonosetron preferred for delayed CINV due to prolonged receptor binding; alternatives include ondansetron, granisetron), PLUS dexamethasone (12mg IV/PO day 1, then 8mg days 2–4), PLUS…

Olanzapine for Refractory Nausea

Olanzapine, an atypical antipsychotic that blocks dopamine (D2), serotonin (5-HT2A/C), histamine (H1), and muscarinic receptors, has emerged as a powerful antiemetic that addresses multiple pathways simultaneously. The pivotal Navari 2016 NEJM trial demonstrated that adding olanzapine 10mg nightly to a standard three-drug HEC regimen significantly improved complete nausea prevention in the delayed phase (68% vs. 23%) and 24-hour complete response rates. As a result, olanzapine was incorporated into the ASCO 2020 guideline update as the fourth drug in the standard HEC regimen. Olanzapine is…

Non-Pharmacological Strategies

Behavioral and dietary approaches complement pharmacological antiemesis and are particularly valuable for anticipatory CINV and mild persistent nausea: Dietary modifications: Eat small, frequent meals (every 2–3 hours) rather than large meals. Choose bland, starchy, non-greasy foods (crackers, toast, rice, bananas). Serve foods cold or at room temperature to minimize cooking odors. Avoid strong smells, spicy, fatty, or overly sweet foods. Stay well hydrated between meals; sip fluids throughout the day. Ginger: Gingerols and shogaols have anti-nausea properties via 5-HT3 antagonism. Ginger…

When to Call Your Care Team

While most CINV is manageable at home, certain situations require prompt medical attention. Contact your oncology team or go to the nearest emergency department if you experience: - Inability to keep any liquids down for more than 24 hours - Signs of dehydration: dizziness upon standing, decreased urination, dark urine, dry mouth - Weight loss greater than 2 pounds in 24 hours - Blood in vomit (hematemesis) — this is a medical emergency - Severe abdominal pain accompanying the nausea - Nausea accompanied by chest pain or shortness of breath Dehydration from severe CINV can require IV fluid…